Lapaquistat Acetate: Development of a Squalene Synthase Inhibitor for the Treatment of Hypercholesterolemia

Circulation - United States
doi 10.1161/circulationaha.110.975284
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

CJ-15,183, a New Inhibitor of Squalene Synthase Produced by a Fungus, Aspergillus Aculeatus.

Journal of Antibiotics
Drug DiscoveryPharmacology
2001English

Self-Consistent Synthesis of the Squalene Synthase Inhibitor Zaragozic Acid C via Controlled Oligomerization

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2008English

YM-53601, a Novel Squalene Synthase Inhibitor, Reduces Plasma Cholesterol and Triglyceride Levels in Several Animal Species

British Journal of Pharmacology
Pharmacology
2000English

Regulation of Squalene Synthase, a Key Enzyme of Sterol Biosynthesis, in Tobacco

Plant Physiology
Plant ScienceGeneticsPhysiology
2002English

Enantioselective Inhibition of Squalene Synthase by Aziridine Analogues of Presqualene Diphosphate

Journal of Organic Chemistry
Organic Chemistry
2010English

Cloning and Sequence Analysis of a Squalene Synthase Gene From Ginkgo Biloba

International Journal of Current Research in Biosciences and Plant Biology
2016English

Treatment of Homozygous Familial Hypercholesterolemia: Challenges and Latest Development

2016English

Transcriptional Modulation of Squalene Synthase Genes in Barley Treated With PGPR

Frontiers in Plant Science
Plant Science
2015English

Furegrelate, a Thromboxane Synthase Inhibitor, Blunts the Development of Pulmonary Arterial Hypertension in Neonatal Piglets

Pulmonary Circulation
PulmonaryRespiratory Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy